A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Trial Profile

A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Completed
Phase of Trial: Phase III

Latest Information Update: 19 May 2017

At a glance

  • Drugs Ozagrel (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Sponsors Kissei Pharmaceutical
  • Most Recent Events

    • 15 May 2017 Status changed from recruiting to completed.
    • 24 Apr 2017 According to a company media release, since the results of the Phase III clinical study conducted in Japan failed to demonstrate the expected efficacy of this drug, Kissei cautiously discussed a future development policy with Teika and has decided to discontinue the development of this drug.
    • 22 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top